King of Prussia, PA (PRWEB) December 10, 2013
Tunnell Consulting, Inc. today announced that Anthony A. Charity, who served in the U.S. Food and Drug Administration (FDA) for more than twenty years, has joined the firm as a Managing Consultant, Quality and Compliance.
“Anthony Charity’s experience at the FDA enables him to provide our life sciences clients with invaluable help in understanding good manufacturing practices, preparing for inspections, and mitigating compliance risks,” said Philippe Cini, Ph.D., Group Vice President. “His expertise complements Tunnell’s longstanding strengths in quality and compliance, areas in which excellence is absolutely critical for pharmaceutical companies.”
Prior to joining Tunnell, Mr. Charity served as FDA Branch Chief for the Dedicated Drug Cadre Division of Medical Products and Tobacco Inspection, Rockville, MD, where he supervised drug investigators who inspected the foreign manufacturing operations of firms who market pharmaceutical products in the U.S.
“I am delighted to join Tunnell’s Quality and Compliance practice, with its long track record of success, its exclusive focus on the pharmaceutical industry, and its proven methodologies for addressing quality and compliance,” said Mr. Charity. “In a regulatory environment that is becoming increasingly science-driven, the firm offers to clients a breadth and depth of resources that is hard to match.”
Prior to his role as a Branch Chief, Mr. Charity served as a Compliance Officer for the FDA’s Center for Drug Evaluation and Research (CDER), Division of Manufacturing and Product Quality. At CDER, he reviewed proposed regulatory actions for conclusiveness and acceptability of evidence; nature and extent of deviations from current good manufacturing practices (cGMPs), and appropriate regulatory action strategy. He is expert at identifying and evaluating cGMP problems in the manufacture and control of act
Copyright©2012 Vocus, Inc.
All rights reserved